Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.46 Billion USD | -1.04% |
| 2022 | 12.38 Billion USD | -0.49% |
| 2021 | 12.74 Billion USD | 41.58% |
| 2020 | 8.78 Billion USD | 14.01% |
| 2019 | 7.77 Billion USD | 11.6% |
| 2018 | 7.11 Billion USD | 20.5% |
| 2017 | 6.13 Billion USD | 77.49% |
| 2016 | 3.07 Billion USD | -25.58% |
| 2015 | 4.83 Billion USD | 19.39% |
| 2014 | 4.21 Billion USD | -9.04% |
| 2013 | 3.45 Billion USD | -58.94% |
| 2012 | 3.49 Billion USD | 43.46% |
| 2011 | 9.26 Billion USD | -13.66% |
| 2010 | 9.13 Billion USD | 5.95% |
| 2009 | 9.49 Billion USD | 2.35% |
| 2008 | 8.22 Billion USD | -4.93% |
| 2007 | 6.43 Billion USD | -13.12% |
| 2006 | 4.25 Billion USD | 41.81% |
| 2005 | 6.22 Billion USD | -0.46% |
| 2004 | 5.61 Billion USD | 26.65% |
| 2003 | 4.2 Billion USD | -7.33% |
| 2002 | 4.3 Billion USD | -16.81% |
| 2001 | 4.39 Billion USD | 50.64% |
| 2000 | 3.4 Billion USD | 0.06% |
| 1999 | 3.97 Billion USD | -0.74% |
| 1998 | 3.9 Billion USD | 8.36% |
| 1997 | 3.56 Billion USD | 6.0% |
| 1996 | 3.3 Billion USD | 9.61% |
| 1995 | 2.94 Billion USD | 11.44% |
| 1994 | 2.65 Billion USD | 13.77% |
| 1993 | 2.4 Billion USD | 36.39% |
| 1992 | 1.95 Billion USD | -10.45% |
| 1991 | 1.93 Billion USD | 9.88% |
| 1990 | 1.76 Billion USD | 15.28% |
| 1989 | 1.52 Billion USD | 11.33% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.72 Billion USD | 12.74% |
| 2024 Q1 | 1.45 Billion USD | -18.47% |
| 2024 Q3 | 1.94 Billion USD | 10.2% |
| 2023 Q2 | 2.46 Billion USD | -0.85% |
| 2023 Q4 | 2.67 Billion USD | 3.24% |
| 2023 Q3 | 2.59 Billion USD | 5.28% |
| 2023 FY | - USD | -1.04% |
| 2023 Q1 | 2.48 Billion USD | 32.98% |
| 2022 FY | - USD | -0.49% |
| 2022 Q1 | 3.5 Billion USD | 18.51% |
| 2022 Q2 | 3.3 Billion USD | -5.6% |
| 2022 Q3 | 2.36 Billion USD | -28.58% |
| 2022 Q4 | 1.86 Billion USD | -20.88% |
| 2021 Q4 | 2.95 Billion USD | -5.89% |
| 2021 FY | - USD | 41.58% |
| 2021 Q2 | 1.97 Billion USD | -26.28% |
| 2021 Q1 | 2.67 Billion USD | -11.23% |
| 2021 Q3 | 3.14 Billion USD | 58.99% |
| 2020 Q3 | 2.05 Billion USD | 70.49% |
| 2020 Q1 | 1.32 Billion USD | -31.36% |
| 2020 FY | - USD | 14.01% |
| 2020 Q4 | 3.01 Billion USD | 47.15% |
| 2020 Q2 | 1.2 Billion USD | -8.86% |
| 2019 Q2 | 1.72 Billion USD | 35.77% |
| 2019 Q4 | 1.92 Billion USD | 10.71% |
| 2019 FY | - USD | 11.6% |
| 2019 Q1 | 1.27 Billion USD | -25.13% |
| 2019 Q3 | 1.73 Billion USD | 0.58% |
| 2018 FY | - USD | 20.5% |
| 2018 Q1 | 1.22 Billion USD | -8.92% |
| 2018 Q2 | 1.52 Billion USD | 24.24% |
| 2018 Q4 | 1.69 Billion USD | 11.7% |
| 2018 Q3 | 1.52 Billion USD | -0.07% |
| 2017 Q3 | 1.3 Billion USD | 51.86% |
| 2017 Q1 | 1.44 Billion USD | 28.76% |
| 2017 Q2 | 858 Million USD | -40.66% |
| 2017 Q4 | 1.34 Billion USD | 3.22% |
| 2017 FY | - USD | 77.49% |
| 2016 Q1 | 649 Million USD | -31.83% |
| 2016 FY | - USD | -25.58% |
| 2016 Q3 | 65 Million USD | -93.18% |
| 2016 Q4 | 1.12 Billion USD | 1627.69% |
| 2016 Q2 | 953 Million USD | 46.84% |
| 2015 FY | - USD | 19.39% |
| 2015 Q4 | 952 Million USD | 9.8% |
| 2015 Q2 | 1.15 Billion USD | 50.32% |
| 2015 Q3 | 867 Million USD | -25.19% |
| 2015 Q1 | 771 Million USD | -21.33% |
| 2014 Q2 | 919 Million USD | 47.75% |
| 2014 FY | - USD | -9.04% |
| 2014 Q3 | 866 Million USD | -5.77% |
| 2014 Q1 | 622 Million USD | -35.07% |
| 2014 Q4 | 980 Million USD | 13.16% |
| 2013 Q1 | 808 Million USD | -73.85% |
| 2013 FY | - USD | -58.94% |
| 2013 Q4 | 958 Million USD | 12.18% |
| 2013 Q3 | 854 Million USD | 2.64% |
| 2013 Q2 | 832 Million USD | 2.97% |
| 2012 Q4 | 3.08 Billion USD | 56.66% |
| 2012 FY | - USD | 43.46% |
| 2012 Q1 | 1.92 Billion USD | -39.07% |
| 2012 Q2 | 2.33 Billion USD | 21.23% |
| 2012 Q3 | 1.97 Billion USD | -15.36% |
| 2011 Q2 | 2.1 Billion USD | 50.9% |
| 2011 Q3 | 605 Million USD | -71.22% |
| 2011 Q4 | 3.15 Billion USD | 421.44% |
| 2011 FY | - USD | -13.66% |
| 2011 Q1 | 1.39 Billion USD | -48.13% |
| 2010 Q3 | 1.16 Billion USD | -30.7% |
| 2010 FY | - USD | 5.95% |
| 2010 Q1 | 1.47 Billion USD | -43.65% |
| 2010 Q2 | 1.68 Billion USD | 14.28% |
| 2010 Q4 | 2.68 Billion USD | 130.53% |
| 2009 FY | - USD | 2.35% |
| 2009 Q3 | 1.96 Billion USD | 17.84% |
| 2009 Q4 | 2.61 Billion USD | 32.65% |
| 2009 Q1 | 1.56 Billion USD | -42.93% |
| 2009 Q2 | 1.67 Billion USD | 6.99% |
| 2008 Q3 | 1.84 Billion USD | 6.65% |
| 2008 FY | - USD | -4.93% |
| 2008 Q4 | 2.73 Billion USD | 47.92% |
| 2008 Q2 | 1.73 Billion USD | 6.16% |
| 2008 Q1 | 1.63 Billion USD | -20.6% |
| 2007 Q2 | 1.57 Billion USD | 12.06% |
| 2007 Q1 | 1.4 Billion USD | -49.5% |
| 2007 Q4 | 2.05 Billion USD | 39.79% |
| 2007 FY | - USD | -13.12% |
| 2007 Q3 | 1.47 Billion USD | -6.77% |
| 2006 Q4 | 2.78 Billion USD | 86.4% |
| 2006 Q3 | 1.49 Billion USD | 102.07% |
| 2006 FY | - USD | 41.81% |
| 2006 Q2 | 740.34 Million USD | -44.4% |
| 2006 Q1 | 1.33 Billion USD | -11.92% |
| 2005 Q3 | 1.1 Billion USD | -17.26% |
| 2005 Q1 | 1.39 Billion USD | -6.15% |
| 2005 FY | - USD | -0.46% |
| 2005 Q4 | 1.51 Billion USD | 37.05% |
| 2005 Q2 | 1.33 Billion USD | -4.54% |
| 2004 Q3 | 1.27 Billion USD | -4.09% |
| 2004 Q1 | 1.36 Billion USD | 4.65% |
| 2004 Q2 | 1.32 Billion USD | -3.03% |
| 2004 Q4 | 1.48 Billion USD | 17.05% |
| 2004 FY | - USD | 26.65% |
| 2003 Q1 | 980.49 Million USD | -2.47% |
| 2003 Q2 | 518 Million USD | -50.16% |
| 2003 Q3 | 1.11 Billion USD | 97.06% |
| 2003 Q4 | 1.47 Billion USD | 12.47% |
| 2003 FY | - USD | -7.33% |
| 2002 Q1 | 1.04 Billion USD | 4.5% |
| 2002 Q4 | 1.17 Billion USD | 9.04% |
| 2002 FY | - USD | -16.81% |
| 2002 Q3 | 913.39 Million USD | 8.8% |
| 2002 Q2 | 1.06 Billion USD | -16.82% |
| 2001 Q2 | 1.08 Billion USD | -51.15% |
| 2001 Q3 | 744.63 Million USD | -18.99% |
| 2001 Q4 | 1.17 Billion USD | 29.47% |
| 2001 FY | - USD | 50.64% |
| 2001 Q1 | 1.08 Billion USD | 126.43% |
| 2000 Q1 | 1.02 Billion USD | -6.99% |
| 2000 Q2 | 1.1 Billion USD | 4.23% |
| 2000 Q3 | 784.72 Million USD | -4.36% |
| 2000 Q4 | 1.12 Billion USD | 17.15% |
| 2000 FY | - USD | 0.06% |
| 1999 Q2 | 1.03 Billion USD | -10.89% |
| 1999 Q4 | 1.03 Billion USD | 33.06% |
| 1999 Q1 | 1.11 Billion USD | 10.8% |
| 1999 FY | - USD | -0.74% |
| 1999 Q3 | 795 Million USD | -26.12% |
| 1998 Q4 | 1.02 Billion USD | 14.46% |
| 1998 FY | - USD | 8.36% |
| 1998 Q3 | 901.2 Million USD | -8.9% |
| 1998 Q2 | 982.39 Million USD | -3.21% |
| 1998 Q1 | 993.4 Million USD | 3.56% |
| 1997 Q3 | 820.1 Million USD | -8.42% |
| 1997 Q4 | 961.62 Million USD | 19.94% |
| 1997 FY | - USD | 6.0% |
| 1997 Q1 | 911.88 Million USD | -0.32% |
| 1997 Q2 | 884.57 Million USD | -3.54% |
| 1996 Q3 | 763.46 Million USD | -7.16% |
| 1996 FY | - USD | 9.61% |
| 1996 Q1 | 838.3 Million USD | 1.42% |
| 1996 Q2 | 807.6 Million USD | -5.5% |
| 1996 Q4 | 893.8 Million USD | 20.29% |
| 1995 FY | - USD | 11.44% |
| 1995 Q4 | 822.78 Million USD | 20.03% |
| 1995 Q2 | 717.85 Million USD | -2.06% |
| 1995 Q1 | 726.56 Million USD | 4.07% |
| 1995 Q3 | 682.12 Million USD | -4.04% |
| 1994 Q2 | 671.59 Million USD | 1.99% |
| 1994 Q3 | 614.62 Million USD | -11.9% |
| 1994 Q4 | 709.15 Million USD | 16.86% |
| 1994 FY | - USD | 13.77% |
| 1994 Q1 | 659.33 Million USD | -11.67% |
| 1993 Q4 | 721.84 Million USD | 32.81% |
| 1993 FY | - USD | 36.39% |
| 1993 Q2 | 551.5 Million USD | -7.77% |
| 1993 Q1 | 564.8 Million USD | -3.59% |
| 1993 Q3 | 569.9 Million USD | 18.19% |
| 1992 Q3 | 554.7 Million USD | 1474.21% |
| 1992 Q2 | 308.3 Million USD | -92.64% |
| 1992 Q4 | 564.8 Million USD | -10.5% |
| 1992 Q1 | 526.1 Million USD | -6.21% |
| 1992 FY | - USD | -10.45% |
| 1991 Q4 | 553.3 Million USD | 28.39% |
| 1991 FY | - USD | 9.22% |
| 1991 Q2 | 467.5 Million USD | -5.38% |
| 1991 Q3 | 446.8 Million USD | -2.52% |
| 1991 Q1 | 468.4 Million USD | -3.92% |
| 1990 Q4 | 496.9 Million USD | 21.45% |
| 1990 FY | - USD | 16.54% |
| 1990 Q3 | 408.8 Million USD | -7.6% |
| 1990 Q2 | 439.9 Million USD | 4.76% |
| 1990 Q1 | 416.5 Million USD | 115.23% |
| 1989 Q3 | 1.31 Billion USD | -0.62% |
| 1989 Q1 | 1.29 Billion USD | 151.23% |
| 1989 Q4 | -2.7 Billion USD | -306.3% |
| 1989 Q2 | 1.31 Billion USD | 1.78% |
| 1989 FY | - USD | 10.99% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Allurion Technologies Inc. | -69.03 Million USD | 15256.958% |
| Artivion, Inc. | 38.14 Million USD | -27331.703% |
| Avanos Medical, Inc. | 53.2 Million USD | -19567.293% |
| Butterfly Network, Inc. | -124.84 Million USD | 8480.859% |
| Butterfly Network, Inc. | -124.84 Million USD | 8480.859% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 1820.138% |
| Boston Scientific Corporation | 3.45 Billion USD | -203.012% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | 70614.894% |
| CONMED Corporation | 182.18 Million USD | -5643.032% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | -491.933% |
| Paragon 28, Inc. | -36.61 Million USD | 28676.501% |
| Glaukos Corporation | -82.11 Million USD | 12841.731% |
| Globus Medical, Inc. | 418.23 Million USD | -2401.68% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | 61430.598% |
| Integer Holdings Corporation | 282.05 Million USD | -3609.508% |
| Medtronic plc | 9.05 Billion USD | -15.537% |
| Nevro Corp. | -78.31 Million USD | 13461.001% |
| Owlet, Inc. | -27.48 Million USD | 38162.498% |
| Penumbra, Inc. | 111.99 Million USD | -9242.298% |
| Vicarious Surgical Inc. | -69.19 Million USD | 15221.69% |
| Smith & Nephew plc | 979 Million USD | -968.744% |
| Sonendo, Inc. | -54.76 Million USD | 19204.221% |
| STERIS plc | 1.41 Billion USD | -640.793% |
| Stryker Corporation | 5.16 Billion USD | -102.771% |
| Vapotherm, Inc. | -34.35 Million USD | 30553.765% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | -327.253% |